JIAYI WU: Open Payments
NPI 1124856984 · CHEVY CHASE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$799 in 35 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $799
Food & beverage: $799
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $121 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $97 |
| PFIZER INC. | 4 | $85 |
| E.R. Squibb & Sons, L.L.C. | 4 | $82 |
| BridgeBio Pharma, Inc. | 2 | $60 |
| Novartis Pharmaceuticals Corporation | 2 | $56 |
| Esperion Therapeutics, Inc. | 2 | $41 |
| Lilly USA, LLC | 2 | $41 |
| Inspire Medical Systems, Inc. | 2 | $40 |
| Daiichi Sankyo Inc. | 1 | $24 |
Products named: Wegovy, JARDIANCE, CAMZYOS, Attruby, ELIQUIS, LEQVIO, NEXLETOL, INSPIRE.
Industry payments across MD — which companies pay providers there.
